1-3 of 3
Vassiliki Poulaki, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NVP-AEW541: A Selective Small Molecule IGF-1R Tyrosine Kinase Inhibitor Is Active Against Multiple Myeloma and Other Hematologic Neoplasias and Solid Tumors.

Nicholas Mitsiades, MD, PhD, Ciaran J. McMullan, Vassiliki Poulaki, MD, PhD, Reshma Shringarpure, PhD, Towia A. Libermann, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Robert L. Schlossman, MD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, PhD, Carlos Garcia-Echeverria, PhD, Francesco Hoffmann, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 766.
https://doi.org/10.1182/blood.V104.11.766.766
Published: 2004
Journal Articles

Avicins: A Novel Class of Anti-Myeloma Agents.

Nicholas Mitsiades, MD, PhD, Ciaran J. McMullan, MSc, Vassiliki Poulaki, MD, PhD, Joseph Negri, David C. Geer, MSc, Valsala Haridas, PhD, Nikhil C. Munshi, MD, PhD, Jordan Gutterman, MD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3405.
https://doi.org/10.1182/blood.V104.11.3405.3405
Published: 2004
Journal Articles

The mTOR Inhibitor RAD001 (everolimus) Is Active Against Multiple Myeloma Cells In Vitro and in Vivo.

Nicholas Mitsiades, MD, PhD, Ciaran McMullan, MSc, Vassiliki Poulaki, MD, PhD, Joseph Negri, Noopur Raje, MD, Shaji Kumar, MD, Despoina Sikoutri, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Paul G. Richardson, MD, Robert L. Schlossman, MD, Andrew L. Kung, MD, PhD, Heidi Lane, PhD, Nikhil C. Munshi, MD, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1496.
https://doi.org/10.1182/blood.V104.11.1496.1496
Published: 2004